Retension Pharmaceuticals, Inc. · NASDAQ:RTSN
Laurence W. Lytton reported a 7.40% stake in Retension Pharmaceuticals, Inc. (Schedule 13G)
Event Oct 13, 2026 · Filed Oct 15, 2026
Laurence W. Lytton reported a 7.40% stake in Retension Pharmaceuticals, Inc., 617,207 shares, as a passive investor on Oct 13, 2026. Filed Oct 15, 2026 (Schedule 13G).
- Stake
- 7.40%
- Shares
- 617,207
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Laurence W. Lytton | 7.40% | 617,207 |
Source
Download original · View original at SEC
Related
- Retension Pharmaceuticals, Inc.
- Laurence W. Lytton
- Retension Pharmaceuticals, Inc. shareholders
- Schedule 13G · Pvg Asset Management Corp · Oct 16, 2026
- Schedule 13G · B Group, Inc. · Oct 16, 2026
- Schedule 13D · Eric Keller · Oct 14, 2026
- Form 4 · Berendt Michael J · Oct 13, 2026
- Form 4 · Berger Franklin M · Oct 13, 2026